Datakosa board meet Oct 23, 2026 for Sep results

Why Datakosa’s October 23 board meeting matters

Datakosa Ltd has informed BSE that its Board of Directors will meet on October 23, 2026. The agenda is to consider, approve, and take on record the company’s unaudited financial results for the quarter and half-year ended September 30, 2026. The board is also scheduled to take note of the statutory auditor’s limited review report for the same period. For investors, this is a standard but important governance event because it sets the timeline for the next set of reported numbers. The exchange filing is procedural and does not disclose the upcoming financial outcomes. Still, it anchors expectations around when the market will get the next earnings update. On the day referenced in the context, Datakosa was shown at a BSE price of ₹15.95.

What the exchange filing says

The BSE intimation states that the company’s board meeting is scheduled on 23/10/2026. The stated purpose is “Quarterly Results,” and the filing explicitly includes the quarter and half-year ended September 30, 2026. Alongside results approval, the board will consider and take note of the limited review report of the statutory auditor. Such limited reviews typically accompany unaudited quarterly financials. The filing is positioned as a compliance update rather than an earnings preview. The company has also had related compliance submissions during the same period, including routine depository and disclosure items.

Trading window closure disclosure

The same context notes a trading window closure beginning October 1, 2026. The closure is described as continuing until 48 hours after the disclosure of results. This is commonly linked to insider trading prevention norms, particularly around unpublished price sensitive information. The update gives stakeholders clarity on the compliance window without adding operational commentary. There is no guidance in the provided text on revenue, margins, or demand trends for the September 2026 quarter. Investors therefore need to wait for the formal disclosure after the board meeting.

A look at the latest quarterly snapshot provided (Q3 FY23-24)

The material also includes a “Q3 FY23-24 Results Summary” for Datakosa. In that snapshot, revenue is stated at ₹2.32 crore, with a quarter-on-quarter increase of 603.03% from ₹0.33 crore. The same line notes a year-on-year decline of 89.63%. Total income in the snapshot is also ₹2.32 crore, with a quarter-on-quarter increase of 152.17% from ₹0.92 crore and a year-on-year decline of 90.24%. Operating profit is shown at ₹-0.16 crore, compared with ₹-0.07 crore in the previous quarter, described as a 128.57% quarter-on-quarter decrease, while also noting 92.38% year-on-year growth. Profit before tax is shown at ₹-0.62 crore versus ₹-0.02 crore QoQ, described as a 3,000.00% quarter-on-quarter decrease and 40.38% year-on-year growth. Net profit is stated at ₹-0.62 crore versus ₹-0.06 crore QoQ, described as a 933.33% quarter-on-quarter decrease and 33.33% year-on-year growth.

Key figures table from the Q3 FY23-24 summary

Standalone June 30, 2026 unaudited results: what is disclosed

The context also references an exchange disclosure dated August 11, 2026, stating that Datakosa enclosed unaudited financial results (standalone) for the quarter ended June 30, 2026, approved by the board at a meeting held that day. Separately, it mentions “Newspaper Publication regarding the Unaudited Financial Results of the Company for the quarter ended June 30, 2026,” which is typically a post-results compliance step. While the detailed quarterly statement values for June 30, 2026 are not provided in the text, the disclosure establishes that the company has been following the routine earnings approval process. It also indicates that the company’s exchange communications include both board outcomes and publication-related filings.

Longer-term annual financial history in the provided data (Mar’22 to Mar’26)

The dataset includes a five-year annual snapshot table for Datakosa with key line items such as net sales, total income, and profit after tax. For Mar’26, total income is stated at ₹20.65 crore, with net sales turnover of ₹19.43 crore and reported PAT of ₹1.43 crore. For Mar’25, total income is ₹6.57 crore with reported PAT of ₹-1.27 crore. For Mar’24, total income is ₹17.21 crore with reported PAT of ₹-2.46 crore. For Mar’23, total income is ₹42.79 crore with reported PAT of ₹-26.26 crore. For Mar’22, total income is ₹106.29 crore with reported PAT of ₹0.72 crore. These figures provide context for the scale and variability in reported income and profitability over time, without indicating what the September 2026 half-year will show.

Annual snapshot table (as provided)

Other governance items referenced

Beyond results-related filings, the context includes a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. It also notes that the company approved the notice convening its 44th Annual General Meeting (AGM) to be held on Wednesday, September 09, 2026 at 11:00 a.m. (IST) through video conferencing or other audio-visual means. These items are standard for listed entities and sit alongside quarterly reporting in the disclosure calendar. They do not provide incremental financial performance information but signal routine compliance.

Broader results calendar context: Marksans Pharma item

The supplied data also includes a separate corporate event line for Marksans Pharma Limited. It states that Marksans Pharma’s board is scheduled to consider and approve unaudited financial results for the quarter and half-year ended September 30, 2026 on November 04, 2026. This does not change Datakosa’s disclosure, but it reflects the broader earnings season cadence where multiple companies schedule board meetings to approve September-quarter numbers.

What to watch next

For Datakosa, the next concrete step is the board meeting on October 23, 2026 and the subsequent results disclosure. The filing indicates that the board will also consider the auditor’s limited review report, which typically accompanies unaudited results. The trading window closure timeline suggests the company is treating the period as price sensitive until results are made public and a 48-hour window passes. Until the exchange release is published, there is no verified information in the provided text on the September 2026 quarter’s revenue, profitability, or balance sheet movement. Investors tracking the stock will likely focus on the published unaudited results and any accompanying notes once disclosed.

Conclusion

Datakosa’s October 23, 2026 board meeting is a scheduled compliance event to approve unaudited financial results for the quarter and half-year ended September 30, 2026 and to note the auditor’s limited review report. The trading window closure beginning October 1, 2026 remains in effect until 48 hours after results disclosure. The next market-relevant update will be the company’s formal results announcement after the board meeting.